Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

YAP1 Activation Rescues Nagashima-type Palmoplantar Keratosis Pathological Features in Skin Organoid Disease Models

ABSTRACT: YAP1 Activation Rescues Nagashima-type Palmoplantar Keratosis Pathological Features in Skin Organoid Disease Models

PROVIDER: PRJNA1206701 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

YAP1 Activation Rescues Nagashima-type Palmoplantar Keratosis Pathological Features in Skin Organoid Disease Models

Project description:YAP1 activation rescues NPPK pathological features Abstract Nagashima-type palmoplantar keratosis (NPPK), a recessive genetic skin disorder, is characterized by the presence of keratosis on the palmar and plantar regions, resulting from SERPINB7 mutation. However, the detail pathogenesis of NPPK remains elusive. This study revealed that SERPINB7 does not interact with proteolytic enzymes directly. Instead, SERPINB7 mutants disrupt keratinocyte proteolysis by down-regulating the expression of KLKs, and MMPs in NPPK epidermis. Mechanistically, SERPINB7 mutants inhibit keratinocyte glycolytic metabolism by reducing HK1 kinase activity, which subsequently impedes the activation, and nuclear translocation of transcription factor YAP1. This cascade ultimately leads to decreased expression of proteolytic enzymes within the KLKs, and MMPs families in keratinocytes. Furthermore, we successfully established a skin organoid disease model harboring the SERPINB7 c.796C>T mutation, faithfully recapitulating the clinical, and molecular features of NPPK lesions. Notably, treatment of NPPK skin organoid models with YAP1 agonists significantly improved the pathological changes of the disease. In summary, our findings offer novel insights into the molecular mechanisms underlying NPPK pathogenesis and identify YAP1 as a promising therapeutic target for this disease.

2025-01-10 | GSE285879 | GEO

LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq]

Project description:Oncogenic KRAS signaling is required for tumor survival in cancers that harbor KRAS mutations. We recently performed a genome-scale expression screen to identify genes that bypass KRAS dependency. Here we demonstrate that the developmental transcription factor LHX9 rescues KRAS suppression in vitro and xenograft models. Furthermore, LHX9 decreases cell sensitivity to KRASG12C and MEK1/2 inhibitors. LHX9 promotes transcriptional changes associated with KRAS. Importantly, YAP1 upregulation by LHX9 is required for the rescue of KRAS suppression. Together we identify LHX9 as a YAP1 transcriptional regulator that permits KRAS-dependent cells to proliferate without KRAS expression.

2018-12-01 | GSE116823 | GEO

LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [ChIP-Seq]

2018-12-01 | GSE116822 | GEO

LHX9 rescues KRAS suppression through transcriptional regulation of YAP1

Project description:LHX9 rescues KRAS suppression through transcriptional regulation of YAP1

| PRJNA480297 | ENA

Gene expression profiling of seborrheic keratosis

Project description:Seborrheic keratosis is benign cutaneous neoplasm, the etiology of which is not well-known. To characterize differential gene expression profiles in seborrheic keratosis, we investigated the genome-wide patterns of gene expression from skin with seborrhic keratosis and uninvolved normal skin using cDNA microarrays.

2013-01-01 | GSE22998 | GEO

LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq]

Project description:LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq]

| PRJNA480295 | ENA

LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [ChIP-Seq]

Project description:LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [ChIP-Seq]

| PRJNA480296 | ENA

Gene expression profiling of seborrheic keratosis

2013-01-01 | E-GEOD-22998 | biostudies-arrayexpress

PRKCI regulates tumor microenvironment through YAP1 [Affymetrix]

Project description:A key feature of serous ovarian cancer is frequent amplification in the 3q26 locus, which harbors the PRKCI gene. Here we show that PRKCI is amplified and overexpressed in a 78% of high-grade serous ovarian carcinoma. Our in vivo studies with orthotopic mouse models establish it as an ovarian cancer oncogene. This oncogenic property of PRKCI is mediated by regulation of YAP1 activity. Accordingly YAP1 knockdown partially rescues PRKCI mediated tumorigenesis. Integrated gene expression profiling and YAP1 promoter occupancy analyses reveal that PRKCI and YAP1 cooperate to transcriptionally regulate genes affecting the tumor immune microenvironment. Consistently, CD11b+Gr1+Ly6G+ MDSCs are increased in the tumor microenvironment of PRKCI over-expressing tumors. Importantly, we show that elevated PRKCI expression in high-grade serous ovarian carcinomas strongly correlated with assignment to immunoreactive subtype. In summary, we identify PRKCI and YAP1 as key mediators of a tumor-promoting immunosuppressive microenvironment in ovarian cancers.

2018-01-15 | GSE57257 | GEO

PRKCI regulates tumor microenvironment through YAP1 [ChIP-Seq]

2018-01-15 | GSE57236 | GEO